Wednesday, May 31, 2006

 

scizophrenia

Newsletters | Log Out | My Homepage
All Sources Medscape MEDLINE Drug Reference

Schizophrenia

Resource Center


Collections of Medscape's key clinical content, selected by our editors - Last updated 05/30/2006


Sections
Overview Content

Our understanding of schizophrenia has evolved over the last century. Pharmacological, psychotherapeutic, and psychosocial treatments have become more effective during the last decade, and great strides have been made in consumer education and reduction of stigma. However, the seriousness of this disorder still presents a challenge to our science and our society to manage and treat more effectively both the acute phases and the long-term aftercare and wellness of an individual. To help meet this challenge, Medscape has created the Schizophrenia Resource Center, which contains a collection of the latest psychiatric and medical news and information on schizophrenia.

FOCUS ON
thumbnailCME/CE Treatment Nonadherence Among Individuals With Schizophrenia: Risk Factors and Strategies for Improvement
Why are patients who respond best to treatment at greater risk of relapse? What are risk factors for adherence to medication and follow-up visits? What evidence-based strategies increase adherence?
thumbnailCME/CE An Ounce of Prevention: Identifying Patients With Prodromal Schizophrenia
The prodromal phase of schizophrenia is the focus of new research and new treatment recommendations. Update your understanding of the prodrome and explore best practices for patients at risk.
News More
May 9, 2006 - The atypical antipsychotic drug olanzapine (Zyprexa) may postpone the conversion to psychosis among individuals with prodromal symptoms. That's based on partial results of the "Prevention through Risk Identification, Management, and Education (PRIME)" trial, conducted between 1997 and 2003 -- although the results were not statistically definitive.

Latest from the Literature
The government needs to take steps to ensure that beneficiaries with mental illnesses aren't forced out of drug plans.
from Health Aff. 2006;25(3):707-719.
from Curr Opin Psychiatry. 2006;19(3):277-281.

Conference Coverage
from May 20 - 25, 2006, Toronto, Ontario, Canada
from the American Association for Geriatric Psychiatry (AAGP) 19th Annual Meeting; March 10-13, 2006; San Juan, Puerto Rico
from Medscape Psychiatry & Mental Health, Posted 12/28/2005
from San Diego, California, on October 5-9, 2005.
from Medscape Psychiatry & Mental Health, Posted 10/17/2005
May 21 - 26, 2005, Atlanta, Georgia
from Medscape Psychiatry & Mental Health, Posted 05/23/2005
March 3-5, 2005; New York, NY

Expert Corner
from Medscape Psychiatry & Mental Health, Posted 04/03/2006
from Medscape Psychiatry & Mental Health, Posted 03/15/2006
from Medscape Psychiatry & Mental Health, Posted 01/20/2006
from Medscape Psychiatry & Mental Health, Posted 01/11/2006

CME Programs
from Medscape Clinical Update, Posted 04/28/2006
from Medscape Clinical Update, Posted 04/17/2006
from Medscape Clinical Update, Posted 04/10/2006
from Medscape Clinical Update, Posted 03/10/2006
from Medscape Clinical Update, Posted 12/20/2005
from Medscape CME Circle, Posted 12/16/2005
from Medscape Medical News, Posted 09/21/2005
from Medscape CME Circle, Posted 06/30/2005
from Medscape Medical News, Posted 05/23/2005

MEDLINE Search
Review the recent literature on schizophrenia using Medscape's MEDLINE database. View comprehensive search results from 1998 to present.



All Sources Medscape MEDLINE Drug Reference
All material on this website is protected by copyright, Copyright © 1994-2006 by Medscape. This website also contains material copyrighted by 3rd parties. Medscape requires Microsoft browsers in versions 6 or higher.

Comments: Post a Comment



<< Home

This page is powered by Blogger. Isn't yours?